Faculty
Main content start
Results for: Faculty
Faculty
-
Dr. Greicius on KQED’s forum discussing the controversial approval of aducanumab.
On June 25th, 2021, Dr. Greicius spoke regarding controversies over the FDA approval of aducan on KQED.
June 26, 2021
-
Dr. Greicius co-authors an opinion piece in the New York Times encouraging the FDA to reject Biogen’s application for aducanumab, their anti-amyloid antibody.
On May 28th, the New York Times published an article co-authored by Dr. Greicius speaking out against the Biogen application for aducanumab
May 28, 2021